Low Bone Mass: Clinical Trials

1 completed, 1 not yet recruiting. 2 Phase 2.

By phase and status

Phase	Trials	Status
Phase 2	2	Completed 1, Not yet recruiting 1

Follow Low Bone Mass: new trials by email Literature Review of Low Bone Mass trials Research Report on Low Bone Mass

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

Trial	Phase	Status	Sponsor	Enrollment	Start	Updated
Study of TST002 Injection in Postmenopausal Women With Osteoporosis or Low Bone Mass Denosumab, Placebo - Postmenopausal Osteoporosis, Low Bone Mass	Phase 2	Not yet recruiting	Transcenta Therapeutics (Hangzhou) Co., Ltd.	110	2026-10-31	2026-09-11
A Transiliac Crest Bone Histology and Histomorphometry Study in Postmenopausal Women With Low Bone Mass or Osteoporosis Previously Treated With Denosumab Previous denosumab - Low Bone Mass, Low Bone Mineral Density	Phase 2	Completed	Amgen	15	2009-06-01	2013-11-15

Narrower conditions

Osteoporosis, Postmenopausal (2)  ·  Bone Diseases, Metabolic (1)  ·  Osteoporosis (1)  ·  Sclerosteosis (1)

Broader conditions

Bone Diseases (2)  ·  Metabolic Diseases (2)  ·  Musculoskeletal Diseases (2)  ·  Nutritional and Metabolic Diseases (2)  ·  Bone Diseases, Metabolic (1)  ·  Osteoporosis (1)

Interventions

Denosumab (1)

Sponsors

Amgen (1)  ·  Transcenta Therapeutics (Hangzhou) Co., Ltd. (1)